As shown in Figure 10, the delivery of DOX and Bcl-2-siRNA simultaneously to an A2780/AD human ovarian cancer cells system, based on MSNs, could address the problem of multidrug resistance of the cancer cells [140]. Here, BCL2 is linked to cancer.